| Website | genechem.com |
| Phone | 514-849-7696 |
| Employees |
GeneChem fund and the changing landscape of the genomics industry, the principals set out to raise their second focused fund, GeneChem Therapeutics Venture Fund L.P.. With committed capital of $136.5 million, the Therapeutics Fund’s objectives were to invest within the genomics industry but specifically in companies developing therapeutics for proliferative disorders including cancer, infectious diseases, inflammation and diabetes.
| Company | Date | Round | Size | Participants |
| Osprey Pharmaceuticals USA | 5/08 | Series A | $11M | 6 |
